Seelos Therapeutics (SEEL)
(Delayed Data from NSDQ)
$0.34 USD
+0.01 (2.82%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.34 0.00 (0.21%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.34 USD
+0.01 (2.82%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.34 0.00 (0.21%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
3 Biotech Stocks Aiming to Reinvent Mental Health Treatment
by Andrew Rocco
Atai, Biogen, and Sage are working to develop new treatments for mental illness.
Is the Options Market Predicting a Spike in Seelos (SEEL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.
Do Options Traders Know Something About Seelos (SEEL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.
Do Options Traders Know Something About Seelos (SEEL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.